Xylem (NYSE:XYL) Stock Sees Heavy Call Option Buying

Key Points

• Unusual bullish options activity drove attention to Xylem, with 20,508 call options traded—771% above the average daily volume.
• Xylem’s shares rose 2.8% to $90.74, supported by director insider buying and several analysts maintaining buy or outperform ratings, although the consensus rating remains “Hold.”
• Fundamentals remain pressured: third-quarter revenue fell 3% year over year and missed estimates, adjusted EPS came in slightly below expectations, and management cut its 2026 outlook, prompting some analysts to lower price targets or downgrade the stock.

Xylem Inc. (NYSE:XYL - Get Free Report) was the target of some unusual options trading on Thursday. Traders acquired 20,508 call options on the stock. This is an increase of 771% compared to the average daily volume of 2,355 call options.

Key Xylem News

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: RBC initiated coverage with a moderate buy rating and a $125 price target, implying substantial upside from recent levels. RBC also reaffirmed its buy rating, while Citigroup, BNP Paribas Exane, Stifel, and Oppenheimer maintained positive ratings despite lowering their targets. RBC Capital Reaffirms Buy Rating
• Positive Sentiment: Unusually heavy call-option activity suggests some traders are positioning for a rebound: 20,508 calls changed hands, about 771% above average volume.
• Positive Sentiment: Some analysts view the selloff as excessive relative to Xylem’s longer-term growth potential. The company’s planned divestitures and new three-segment structure could streamline operations and sharpen its strategic focus.
• Neutral Sentiment: Analyst opinion is mixed. UBS lowered its price target to $99 and assigned a neutral rating, while Stifel reduced its target to $114 but retained a buy rating. The target reductions indicate more cautious near-term expectations even though most targets remain above the current share price.
• Negative Sentiment: Xylem’s third-quarter revenue of $2.20 billion missed the $2.28 billion consensus estimate, while adjusted EPS of $1.44 was slightly below expectations. Revenue declined 3% year over year, reinforcing concerns about slowing demand. Xylem Stock Price Sinks After Q3 Results
• Negative Sentiment: Management cut its 2026 outlook, a key reason for the post-earnings decline. JPMorgan downgraded the stock to underweight and lowered its target to $90, while elevated put-option activity points to continued downside hedging. Xylem Cuts 2026 Outlook
• Negative Sentiment: A law firm announced an investigation into potential securities-law violations related to the earnings shortfall, adding a further reputational and legal risk for shareholders. Xylem Investigation Notice

Analysts Set New Price Targets

XYL has been the subject of several analyst reports. Oppenheimer cut their price target on shares of Xylem from $150.00 to $135.00 and set an "outperform" rating for the company in a report on Wednesday. Wolfe Research started coverage on shares of Xylem in a report on Tuesday, September 15th. They set a "peer perform" rating on the stock. Jefferies Financial Group lifted their price target on shares of Xylem from $145.00 to $150.00 and gave the company a "buy" rating in a research report on Monday, August 24th. Royal Bank Of Canada dropped their price objective on Xylem from $135.00 to $125.00 and set an "outperform" rating for the company in a research note on Wednesday. Finally, The Goldman Sachs Group decreased their target price on Xylem from $160.00 to $138.00 and set a "buy" rating on the stock in a research report on Wednesday. Nine investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Xylem has an average rating of "Hold" and a consensus target price of $121.31.

Insider Buying and Selling

In other news, Director D Koch acquired 11,000 shares of the firm's stock in a transaction dated Thursday, October 29th. The stock was acquired at an average cost of $89.60 per share, with a total value of $985,600.00. Following the completion of the acquisition, the director owned 12,247 shares of the company's stock, valued at $1,097,331.20. The trade was a 882.12% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.32% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Xylem

A number of hedge funds have recently bought and sold shares of the business. XXEC Inc. acquired a new position in Xylem during the second quarter valued at $850,841,000. BlackRock Inc. acquired a new stake in shares of Xylem during the 2nd quarter valued at $2,959,730,000. Bank of New York Mellon Corp purchased a new position in Xylem in the second quarter valued at about $552,313,000. Hsbc Holdings PLC acquired a new position in Xylem in the 2nd quarter worth about $319,785,000. Finally, Deutsche Bank AG purchased a new stake in shares of Xylem during the 2nd quarter worth about $223,165,000. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Trading Up 2.8%

NYSE:XYL traded up $2.51 on Thursday, reaching $90.74. The stock had a trading volume of 4,918,434 shares, compared to its average volume of 2,172,384. Xylem has a 12-month low of $87.40 and a 12-month high of $154.27. The company has a market cap of $21.19 billion, a price-to-earnings ratio of 21.61, a P/E/G ratio of 1.75 and a beta of 1.00. The firm's fifty day moving average is $105.98 and its two-hundred day moving average is $118.05. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.61 and a quick ratio of 1.24.

Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing the consensus estimate of $1.45 by ($0.01). Xylem had a net margin of 11.15% and a return on equity of 11.77%. The business had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.28 billion. During the same quarter in the previous year, the company posted $1.37 earnings per share. The business's revenue for the quarter was down 3.0% compared to the same quarter last year. Equities analysts expect that Xylem will post 5.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Investors of record on Thursday, August 27th were given a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.9%. Xylem's payout ratio is 40.95%.

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.